Загрузка...
PRESCIENT: Platform for the Rapid Evaluation of Antibody Success using Integrated Microfluidics Enabled Technology
Identifying antibodies (Abs) that neutralize infectious agents is the first step for developing therapeutics, vaccines, and diagnostic tools for those infectious agents. However, current approaches for identifying neutralizing Abs (nAbs) typically rely on dilution-based assays that are costly, ineff...
Сохранить в:
| Опубликовано в: : | Lab Chip |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7269184/ https://ncbi.nlm.nih.gov/pubmed/32196032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c9lc01165j |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|